NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation
Germline mono-allelic loss of the tumour suppressor NF1 predisposes patients to the development of benign lesions but rarely further progression into cancer development. Here the authors use mouse models to show that an NF1 heterozygous microenvironment accelerates the formation of benign tumours bu...
Main Authors: | Jean-Philippe Brosseau, Chung-Ping Liao, Yong Wang, Vijay Ramani, Travis Vandergriff, Michelle Lee, Amisha Patel, Kiyoshi Ariizumi, Lu Q. Le |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2018-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-07452-y |
Similar Items
-
Heterozygosity for Pten promotes tumorigenesis in a mouse model of medulloblastoma.
by: Robert C Castellino, et al.
Published: (2010-05-01) -
Mechanisms of increased risk of tumorigenesis in <it>Atm </it>and <it>Brca1 </it>double heterozygosity
by: Wang Jufang, et al.
Published: (2011-08-01) -
Loss of heterozygosity of TRIM3 in malignant gliomas
by: Dolder Béatrice, et al.
Published: (2009-02-01) -
NF-kappaB in Lung Tumorigenesis
by: William N. Rom, et al.
Published: (2011-12-01) -
Scaffold attachment factor B1 (SAFB1) heterozygosity does not influence Wnt-1 or DMBA-induced tumorigenesis
by: Lewis Michael T, et al.
Published: (2009-03-01)